Abstract
Described herein is (3,5-dibromo-4-hydroxyphenyl)(6-hydroxy-2-(1-hydroxyethyl)benzofuran-3-yl-4,5,7-d3)methanone, or a pharmaceutically acceptable salt or solvate thereof, and methods for treating or preventing gout or hyperuricemia comprising the administration of the compound.
Full Text
What is claimed is:
Described herein is (3,5-dibromo-4-hydroxyphenyl)(6-hydroxy-2-(1-hydroxyethyl)benzofuran-3-yl-4,5,7-d3)methanone, or a pharmaceutically acceptable salt or solvate thereof, and methods for treating or preventing gout or hyperuricemia comprising the administration of the compound.
Timeline
Filed
03/12/2026Published
07/16/2026Granted
Not AvailableIPC Codes(4)
C07D 307/80:Radicals substituted by oxygen atoms
A61K 9/00:Medicinal preparations characterised by special physical form
A61K 31/343:condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone